A 3.2 Mb deletion on 18q12 in a patient with childhood autism and high-grade myopia

European Journal of Human Genetics : EJHG
Mette GillingNiels Tommerup

Abstract

Autism spectrum disorders (ASDs) are a heterogeneous group of disorders with unknown aetiology. Even though ASDs are suggested to be among the most heritable complex disorders, only a few reproducible mutations leading to susceptibility for ASD have been identified. In an attempt to identify ASD susceptibility genes through chromosome rearrangements, we investigated a female patient with childhood autism and high-grade myopia, and an apparently balanced de novo translocation, t(5;18)(q34;q12.2). Further analyses revealed a 3.2 Mb deletion encompassing 17 genes at the 18q break point and an additional deletion of 1.27 Mb containing two genes on chromosome 4q35. Q-PCR analysis of 14 of the 17 genes deleted on chromosome 18 showed that 11 of these genes were expressed in the brain, suggesting that haploinsufficiency of one or more genes may have contributed to the childhood autism phenotype of the patient. Identification of multiple genetic changes in this patient with childhood autism agrees with the most frequently suggested genetic model of ASDs as complex, polygenic disorders.

References

Jan 1, 1979·American Journal of Medical Genetics·M G WilsonE Siris
Dec 1, 1988·Journal of Autism and Developmental Disorders·G R DeLong, J T Dwyer
Mar 1, 1980·Journal of Autism and Developmental Disorders·E SchoplerK Daly
Dec 4, 1995·American Journal of Medical Genetics·G StrathdeeJ Overhauser
Jul 17, 1999·Trends in Neurosciences·E CattaneoC De-Fraja
Jul 27, 1999·American Journal of Human Genetics·N RischR M Myers
Apr 20, 2000·Journal of Abnormal Child Psychology·M Rutter
May 18, 2000·Human Molecular Genetics·J K MillarD J Porteous
May 19, 2000·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·C De-FrajaE Cattaneo
Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·R G CollumC Schindler
Apr 6, 2001·Journal of Medical Genetics·M McEntagartM D King
Dec 6, 2001·Nature Reviews. Genetics·S E Folstein, B Rosen-Sheidley
Feb 9, 2002·Brain Research. Molecular Brain Research·E E MorrisonJ M Askham
May 7, 2002·American Journal of Medical Genetics·Marlene B LauritsenHenrik Ewald
Nov 20, 2002·Cytogenetic and Genome Research·M MeinsF Laccone
Mar 28, 2003·Biochimica Et Biophysica Acta·Kathryn M Taylor, Robert I Nicholson
Sep 10, 2003·Journal of Autism and Developmental Disorders·Eric Fombonne
May 8, 2004·Science·Gill BejeranoDavid Haussler
Aug 3, 2004·Nature Genetics·A John IafrateCharles Lee
Aug 27, 2004·Brain : a Journal of Neurology·Saskia J M C PalmenChristoph Schmitz
Dec 14, 2004·Genome Research·Ivan OvcharenkoLisa Stubbs
Mar 8, 2005·Gene Expression Patterns : GEP·Michelle DownAndrew W Boyd
May 17, 2005·Nature Genetics·Eray TuzunEvan E Eichler
May 25, 2005·Journal of Autism and Developmental Disorders·Mohammad Ghaziuddin
Jan 19, 2006·American Journal of Medical Genetics. Part a·Tarja LinnankiviHelena Pihko
Jan 27, 2006·International Clinical Psychopharmacology·Anna Wirz-Justice
Aug 12, 2006·Genome Research·Ryan E MillsScott E Devine
Sep 23, 2006·Science·Fowzan S AlkurayaRichard L Maas
Nov 24, 2006·Nature·Richard RedonMatthew E Hurles
May 17, 2007·Molecular Psychiatry·J MelkeT Bourgeron
Jul 20, 2007·Human Genetics·George ZogopoulosSteven Gallinger

❮ Previous
Next ❯

Citations

Jul 31, 2008·American Journal of Medical Genetics. Part a·Gene S Fisch
Jun 4, 2013·European Journal of Medical Genetics·Peter WangM E Suzanne Lewis
Apr 14, 2017·American Journal of Medical Genetics. Part a·Rita BaroneRenata Rizzo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.